Skip to content

GSKGSK PLC-SPON ADR

CUSIP 37733W204 · depositary receipt

9 tracked investors held GSK PLC-SPON ADR (GSK) at the end of Q3 2026, worth $5.2B in total. The largest holder was Dodge & Cox, with 1.1% of its portfolio. Sarah Ketterer sold out of its position this quarter.

Holders · Q3 2026
9
New holders
0
Value held
$5.2B
Quarter-end price (est.)
$48.17

Investors holding GSK · Q3 2026

InvestorWeightSharesValueChange
Dodge & Cox
Dodge & Cox
1.12%43,183,117$2.1BREDUCE-10.4%
Ken Fisher
Fisher Asset Management, LLC
0.49%35,351,693$1.7BREDUCE-1.0%
PRIMECAP Management
PRIMECAP Management Co
0.75%25,192,138$1.2BADD0.0%
Jeremy Grantham
Grantham, Mayo, Van Otterloo & Co. LLC
0.40%3,917,951$188.7MADD+8.8%
Kahn Brothers Group
Kahn Brothers Group Inc
0.91%113,552$5.5MREDUCE-28.3%
Hillman Capital Management
Hillman Capital Management, Inc.
3.31%91,962$4.4MREDUCE-0.5%
Tweedy Browne
Tweedy, Browne Co LLC
0.30%77,439$3.7MREDUCE-5.0%
Richard Pzena
Pzena Investment Management LLC
0.00%28,964$1.4MADD+18.2%
Murray Stahl
Horizon Kinetics Asset Management LLC
0.01%23,000$1.1MREDUCE-4.3%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Sarah Ketterer0.00%7,163$375.5KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026901$5.2B$48.17
Q2 20261000$5.9B$52.42
Q1 20261000$6.8B$55.19
Q4 20251000$6.4B$49.04